ciglitazone has been researched along with Emphysema in 2 studies
ciglitazone: structure given in second source; PPAR agonist used for type II diabetes
ciglitazone : An aromatic ether that consists of 1,3-thiazolidine-2,4-dione with position 5 substituted by a 4-[(1-methylcyclohexyl)methoxy]benzyl group. A selective PPARgamma agonist.
Emphysema: A pathological accumulation of air in tissues or organs.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kelly, NJ | 1 |
Shapiro, SD | 1 |
Shan, M | 1 |
You, R | 1 |
Yuan, X | 1 |
Frazier, MV | 1 |
Porter, P | 1 |
Seryshev, A | 1 |
Hong, JS | 1 |
Song, LZ | 1 |
Zhang, Y | 1 |
Hilsenbeck, S | 1 |
Whitehead, L | 1 |
Zarinkamar, N | 1 |
Perusich, S | 1 |
Corry, DB | 1 |
Kheradmand, F | 1 |
2 other studies available for ciglitazone and Emphysema
Article | Year |
---|---|
PPARĪ³ in emphysema: blunts the damage and triggers repair?
Topics: Animals; Emphysema; Humans; PPAR gamma; Smoking; Thiazolidinediones | 2014 |
Agonistic induction of PPARĪ³ reverses cigarette smoke-induced emphysema.
Topics: Alveolar Epithelial Cells; Animals; Case-Control Studies; Cells, Cultured; Coculture Techniques; Den | 2014 |